Vir Biotechnology Inc (VIR)
7.34
-0.03
(-0.41%)
USD |
NASDAQ |
Dec 20, 16:00
7.24
-0.10
(-1.36%)
After-Hours: 20:00
Vir Biotechnology Profit Margin (Quarterly): -73.95K% for Sept. 30, 2024
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Janux Therapeutics Inc | -6.39K% |
| Biomarin Pharmaceutical Inc | 14.22% |
| Arbutus Biopharma Corp | -1.47K% |
| GlycoMimetics Inc | -- |
| FibroGen Inc | -36.87% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -35.62% |
| Return on Assets | -29.88% |
| Return on Invested Capital | -35.62% |
| Gross Profit Margin (Quarterly) | 82.70% |
| Operating Margin (Quarterly) | -75.64K% |
| Return on Net Operating Assets | -280.9% |